Replimune Group Inc. Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was ...
T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. 1.6M Mar 31, 2026 1.71% 25,402,410 T. Rowe Price Health Sciences Fund, Inc. 1.43M Mar 31, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results